VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - TSX:VHI - CA92847V5018 - Common Stock
10.96 CAD
-0.12 (-1.08%)
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 9 industry peers in the Health Care Technology industry. VHI has an excellent profitability rating, but there are some minor concerns on its financial health. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VHI very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
VHI's Return On Assets of 1.79% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Return On Equity of 2.71% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Return On Invested Capital of 3.20%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 3.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROIC | 3.2% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.99%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Operating Margin (12.27%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VHI has grown nicely.
With an excellent Gross Margin value of 80.89%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
VHI has more shares outstanding than it did 5 years ago.
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.01 indicates that VHI is not in any danger for bankruptcy at the moment.
VHI has a Altman-Z score of 5.01. This is in the better half of the industry: VHI outperforms 66.67% of its industry peers.
The Debt to FCF ratio of VHI is 1.16, which is an excellent value as it means it would take VHI, only 1.16 years of fcf income to pay off all of its debts.
VHI has a Debt to FCF ratio of 1.16. This is in the better half of the industry: VHI outperforms 77.78% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that VHI is not too dependend on debt financing.
The Debt to Equity ratio of VHI (0.08) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 5.01 |
ROIC/WACC0.35
WACC9.03%
2.3 Liquidity
VHI has a Current Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.59, VHI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
VHI has a Quick Ratio of 1.59. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI has a Quick ratio of 1.59. This is in the better half of the industry: VHI outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
VHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
VHI shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.68%.
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
3.2 Future
Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.60% on average per year.
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.88% yearly.
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue Next Year53.4%
Revenue Next 2Y35.87%
Revenue Next 3Y25.88%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 109.60 indicates a quite expensive valuation of VHI.
Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.86.
Based on the Price/Forward Earnings ratio of 35.00, the valuation of VHI can be described as expensive.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.29, VHI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.6 | ||
| Fwd PE | 35 |
4.2 Price Multiples
VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 51.12 | ||
| EV/EBITDA | 33.97 |
4.3 Compensation for Growth
VHI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 82.60% in the coming years.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y111.49%
EPS Next 3Y82.6%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (10/2/2025, 7:00:00 PM)
10.96
-0.12 (-1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap687.30M
Analysts81.54
Price Target15.84 (44.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.3%
Min EPS beat(2)-54.3%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-35.59%
Min EPS beat(4)-54.3%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.95%
EPS beat(12)1
Avg EPS beat(12)-44.36%
EPS beat(16)2
Avg EPS beat(16)-71.47%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)0.61%
Max Revenue beat(2)7.24%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)7.24%
Revenue beat(8)6
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)2.84%
Revenue beat(16)12
Avg Revenue beat(16)3.4%
PT rev (1m)0%
PT rev (3m)11.8%
EPS NQ rev (1m)-12.51%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-13.08%
EPS NY rev (3m)-46.81%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)32.02%
Revenue NY rev (1m)3.16%
Revenue NY rev (3m)17.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.6 | ||
| Fwd PE | 35 | ||
| P/S | 8.32 | ||
| P/FCF | 51.12 | ||
| P/OCF | 48.31 | ||
| P/B | 3.77 | ||
| P/tB | 22.1 | ||
| EV/EBITDA | 33.97 |
EPS(TTM)0.1
EY0.91%
EPS(NY)0.31
Fwd EY2.86%
FCF(TTM)0.21
FCFY1.96%
OCF(TTM)0.23
OCFY2.07%
SpS1.32
BVpS2.91
TBVpS0.5
PEG (NY)1.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROCE | 5.04% | ||
| ROIC | 3.2% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% | ||
| FCFM | 16.27% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.87 | ||
| Cap/Depr | 10.65% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.38% | ||
| Profit Quality | 271.64% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 5.01 |
F-Score3
WACC9.03%
ROIC/WACC0.35
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y67.73%
EPS Next 2Y111.49%
EPS Next 3Y82.6%
EPS Next 5YN/A
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
Revenue Next Year53.4%
Revenue Next 2Y35.87%
Revenue Next 3Y25.88%
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y81.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.62%
OCF growth 3YN/A
OCF growth 5YN/A